Classical Forms of Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Adults
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
During childhood, the main aims of the medical treatment of congenital adrenal hyperplasia (CAH) secondary to 21-hydroxylase are to prevent salt loss and virilization and to attain normal stature and normal puberty. As such, there is a narrow therapeutic window through which the intended results can be achieved. In adulthood, the clinical management has received little attention, but recent studies have shown the relevance of long-term follow-up of these patients. The aims here are to review the multiple clinical, hormonal and metabolic abnormalities that could be found in adult CAH patients as such a decrease in bone mineral density, overweight and disturbed reproductive functions. In women with classic CAH, a low fertility rate is reported, and is probably the consequence of multiple factors including neuroendocrine and hormonal factors, feminizing surgery, and psychological factors. Men with CAH may present hypogonadism either through the effect of adrenal rests or from suppression of gonadotropins resulting in infertility. Therefore a multidisciplinary team with knowledge of CAH should carefully follow up these patients, from childhood through to adulthood, to avoid these complications and to ensure treatment compliance and tight control of the adrenal androgens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Congenital adrenal hyperplasia due to 21-hydroxylase deficiency*
White, P. C., & Speiser, P. W. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0398 · Cited by 1,432
Congenital adrenal hyperplasia
Speiser, P. W., & White, P. C. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021561 · Cited by 1,405
Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency)
Dupont, B., Oberfield, S. E., Smithwick, E. M., Lee, T. D., & Levine, L. S. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90362-2 · Cited by 371
Stikkelbroeck, N. M. M. L., Otten, B. J., Pasic, A., Jager, G. J., Sweep, C. G. J. F., Noordam, K., & Hermus, A. R. M. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8090 · Cited by 305
Barnes, R. B., Rosenfield, R. L., Ehrmann, D. A., Cara, J. F., Cuttler, L., Levitsky, L. L., & Rosenthal, I. M. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.5.7962325 · Cited by 304 · cited 1×
“Elevated progesterone or other sex steroid levels could induce abnormal ovarian function by programming the hypothalamus early in development [”
BackgroundNewborn screening for congenital adrenal hyperplasia
Therrell, B. L. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70017-3 · Cited by 221 · cited 1×
“The lives of patients with CAH have improved greatly since the discovery that cortisone was an effective treatment for the disorder in the 1950s. Neonatal screening is being done in several countries, and DNA-based prenatal diagnosis is now feasible [”
BackgroundVölkl, T. M. K., Simm, D., Beier, C., & Dörr, H. G. (2006) · PEDIATRICS · doi:10.1542/peds.2005-1005 · Cited by 184 · cited 1×
“reports on CAH patients. One study has showed an increased risk of obesity among children and adolescents with classic CAH due to 21-OH deficiency, compared with a reference population [”
Falhammar, H., Filipsson, H., Holmdahl, G., Janson, P.-O., Nordenskjöld, A., Hagenfeldt, K., & Thorén, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1350 · Cited by 167 · cited 1×
“Another recent study showed higher insulin levels in the CAH women above 30 years compared with controls. Moreover, they reported a high frequency of gestational diabetes among these patients, potentially indicating a higher risk of developing diabetes in the near future [”
BackgroundCharmandari, E., Weise, M., Bornstein, S. R., Eisenhofer, G., Keil, M. F., Chrousos, G. P., & Merke, D. P. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.5.8456 · Cited by 164
Insulin insensitivity in adrenal hyperplasia due to nonclassical steroid 21-hydroxylase deficiency.
Speiser, P. W., Serrat, J., New, M. I., & Gertner, J. M. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.75.6.1464643 · Cited by 143
Claahsen-van der Grinten, H. L., Otten, B. J., Takahashi, S., Meuleman, E. J. H., Hulsbergen-van de Kaa, C., Sweep, F. C. G. J., & Hermus, A. R. M. M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1311 · Cited by 139
Girgis, R., & Winter, J. S. D. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4320 · Cited by 139
Stikkelbroeck, N. M. M. L., Oyen, W. J. G., van der Wilt, G.-J., Hermus, A. R. M. M., & Otten, B. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021074 · Cited by 138
Krone, N., Wachter, I., Stefanidou, M., Roscher, A. A., & Schwarz, H. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01359.x · Cited by 135
Obesity in 21-hydroxylase deficient patients
Cornean, R. E., Hindmarsh, P. C., & Brook, C. G. D. (1998) · Archives of Disease in Childhood · doi:10.1136/adc.78.3.261 · Cited by 135
Hoimes‐Walker, D. J., Conway, G. S., Honour, J. W., Rumsby, G., & Jacobs, H. S. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02034.x · Cited by 134
Sartorato, P., Zulian, E., Benedini, S., Mariniello, B., Schiavi, F., Bilora, F., Pozzan, G., Greggio, N., Pagnan, A., Mantero, F., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1711 · Cited by 132 · cited 1×
“Thus, there is a need for long-term follow-up and further studies of insulin sensitivity in CAH. In another study, an increased intima-media thickness has been reported suggesting there is a need for long-term follow-up and further studies of the determination of cardiovascular risk in CAH [”
BackgroundRoche, E. F., Charmandari, E., Dattani, M. T., & Hindmarsh, P. C. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01757.x · Cited by 113
Long-Term Outcome of Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
Bachelot, A., Plu-Bureau, G., Thibaud, E., Laborde, K., Pinto, G., Samara, D., Nihoul-Fékété, C., Kuttenn, F., Polak, M., & Touraine, P. (2007) · Hormone Research in Paediatrics · doi:10.1159/000098017 · Cited by 106
Self-citationPregnancy outcomes in women with congenital virilizing adrenal hyperplasia
Lo, J. C., & Grumbach, M. M. (2001) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(08)70027-6 · Cited by 98
Bone density in young patients with congenital adrenal hyperplasia
Mora, S., Saggion, F., Russo, G., Weber, G., Bellini, A., Prinster, C., & Chiumello, G. (1996) · Bone · doi:10.1016/8756-3282(96)00003-8 · Cited by 95
Gussinyé, M., Carrascosa, A., Potau, N., Enrubia, M., Vicens-Calvet, E., Ibáñez, L., & Yeste, D. (1997) · PEDIATRICS · doi:10.1542/peds.100.4.671 · Cited by 90
Height, Bone Mineral Density and Bone Markers in Congenital Adrenal Hyperplasia
Paganini, C., Radetti, G., Livieri, C., Braga, V., Migliavacca, D., & Adami, S. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053253 · Cited by 87
Sciannamblo, M., Russo, G., Cuccato, D., Chiumello, G., & Mora, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2823 · Cited by 82
Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia
Guo, C., Weetman, A. P., & Eastell, R. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.00851.x · Cited by 79
Stikkelbroeck, N. M. L., Hermus, A. M. M., Schouten, D., Suliman, H., Jager, G., Braat, D. M., & Otten, B. (2004) · European Radiology · doi:10.1007/s00330-004-2329-x · Cited by 71
Christiansen, P., Mølgaard, C., & Müller, J. (2004) · Hormone Research in Paediatrics · doi:10.1159/000075588 · Cited by 61
Outcome of bilateral adrenalectomy in congenital adrenal hyperplasia: one unit’s experience
Ogilvie, C. M., Rumsby, G., Kurzawinski, T., & Conway, G. S. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02096 · Cited by 55
Ovarian adrenal-like tissue in congenital adrenal hyperplasia
Russo, G., Paesano, P., Taccagni, G., Del Maschio, A., & Chiumello, G. (1998) · New England Journal of Medicine · doi:10.1056/nejm199809173391220 · Cited by 50
de Almeida Freire, P. O., de Lemos-Marini, S. H. V., Maciel-Guerra, A. T., Morcillo, A. M., Matias Baptista, M. T., de Mello, M. P., & Guerra Jr., G. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0434-6 · Cited by 47
Cited by
Granger, D. A., Hibel, L. C., Fortunato, C. K., & Kapelewski, C. H. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.06.017 · Cited by 295
Treatment and health outcomes in adults with congenital adrenal hyperplasia
Han, T. S., Walker, B. R., Arlt, W., & Ross, R. J. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.239 · Cited by 102
Reisch, N., Hahner, S., Bleicken, B., Flade, L., Pedrosa Gil, F., Loeffler, M., Ventz, M., Hinz, A., Beuschlein, F., Allolio, B., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03920.x · Cited by 78
Concolino, P., Mello, E., Minucci, A., Giardina, E., Zuppi, C., Toscano, V., & Capoluongo, E. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-72 · Cited by 47
Sanches, S. A., Wiegers, T. A., Otten, B. J., & Claahsen-van der Grinten, H. L. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-2 · Cited by 38
Metadata
- Authors
- Bachelot, A., Chakthoura, Z., Rouxel, A., Dulon, J., & Touraine, P.
- Venue
- Hormone Research in Paediatrics
- Publisher
- S. Karger AG
- Published
- 2008
- Volume
- 69
- Issue
- 4
- Pages
- 203-211
- ISSN
- 1663-2818 (ISSN-L)
- 1663-2826
- OpenAlex
- W2121515067
- Cited by
- 37
- References
- 30
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.